|
1
|
Rafieva LM and Gasanov EV: Neurotrophin
propeptides: Biological functions and molecular mechanisms. Curr
Protein Pept Sci. 17:298–305. 2016. View Article : Google Scholar
|
|
2
|
Arévalo JC and Deogracias R: Mechanisms
controlling the expression and secretion of BDNF. Biomolecules.
13:7892023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang M, Xie Y and Qin D: Proteolytic
cleavage of proBDNF to mBDNF in neuropsychiatric and
neurodegenerative diseases. Brain Res Bull. 166:172–184. 2021.
View Article : Google Scholar
|
|
4
|
Yang J, Harte-Hargrove LC, Siao CJ,
Marinic T, Clarke R, Ma Q, Jing D, Lafrancois JJ, Bath KG, Mark W,
et al: proBDNF negatively regulates neuronal remodeling, synaptic
transmission, and synaptic plasticity in hippocampus. Cell Rep.
7:796–806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Edman S, Horwath O, Van der Stede T,
Blackwood SJ, Moberg I, Stromlind H, Nordström F, Ekblom M, Katz A,
Apró W and Moberg M: Pro-brain-derived neurotrophic factor (BDNF),
but not mature BDNF, is expressed in human skeletal muscle:
Implications for exercise-induced neuroplasticity. Function (Oxf).
5:zqae52024.
|
|
6
|
Gibon J and Barker PA: Neurotrophins and
proneurotrophins: Focus on synaptic activity and plasticity in the
brain. Neuroscientist. 23:587–604. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eggert S, Kins S, Endres K and Brigadski
T: Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their
common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in
the progression of Alzheimer's disease. Biol Chem. 403:43–71. 2022.
View Article : Google Scholar
|
|
8
|
Hempstead BL: Deciphering proneurotrophin
actions. Handb Exp Pharmacol. 220:17–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teng HK, Teng KK, Lee R, Wright S, Tevar
S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, et al: ProBDNF
induces neuronal apoptosis via activation of a receptor complex of
p75NTR and sortilin. J Neurosci. 25:5455–5463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anastasia A, Deinhardt K, Chao MV, Will
NE, Irmady K, Lee FS, Hempstead BL and Bracken C: Val66Met
polymorphism of BDNF alters prodomain structure to induce neuronal
growth cone retraction. Nat Commun. 4:24902013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Je HS, Yang F, Ji Y, Nagappan G, Hempstead
BL and Lu B: Role of pro-brain-derived neurotrophic factor
(proBDNF) to mature BDNF conversion in activity-dependent
competition at developing neuromuscular synapses. Proc Natl Acad
Sci USA. 109:15924–15929. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carlino D, De Vanna M and Tongiorgi E: Is
altered BDNF biosynthesis a general feature in patients with
cognitive dysfunctions? Neuroscientist. 19:345–353. 2013.
View Article : Google Scholar
|
|
13
|
Buhusi M, Etheredge C, Granholm AC and
Buhusi CV: Increased hippocampal ProBDNF contributes to memory
impairments in aged mice. Front Aging Neurosci. 9:2842017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kailainathan S, Piers TM, Yi JH, Choi S,
Fahey MS, Borger E, Gunn-Moore FJ, O'Neill L, Lever M, Whitcomb DJ,
et al: Activation of a synapse weakening pathway by human Val66 but
not Met66 pro-brain-derived neurotrophic factor (proBDNF).
Pharmacol Res. 104:97–107. 2016. View Article : Google Scholar :
|
|
15
|
Pérez Palmer N, Trejo Ortega B and Joshi
P: Cognitive impairment in older adults: Epidemiology, diagnosis,
and treatment. Psychiatr Clin North Am. 45:639–661. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ampil ER, Ong PA, Krespi Y and Yang YH: A
review of SaiLuoTong (MLC-SLT) development in vascular cognitive
impairment and dementia. Front Pharmacol. 15:13438202024.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D,
Li Y, Li Y, Zhu M, Jiao H, et al: Prevalence, risk factors, and
management of dementia and mild cognitive impairment in adults aged
60 years or older in China: A cross-sectional study. Lancet Public
Health. 5:e661–e671. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aderinto N, Olatunji G, Abdulbasit M,
Ashinze P, Faturoti O, Ajagbe A, Ukoaka B and Aboderin G: The
impact of diabetes in cognitive impairment: A review of current
evidence and prospects for future investigations. Medicine
(Baltimore). 102:e355572023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Qin TS, Bo Y, Li YJ, Liu RS, Yu
Y, Li XD, He JC, Ma AX, Tao DP, et al: The role of the intestinal
flora and its derivatives in neurocognitive disorders: A narrative
review from surgical perspective. Mol Neurobiol. 62:1404–1414.
2025. View Article : Google Scholar :
|
|
20
|
Benedict RHB, Amato MP, Deluca J and
Geurts JJG: Cognitive impairment in multiple sclerosis: Clinical
management, MRI, and therapeutic avenues. Lancet Neurol.
19:860–871. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haroon NN, Austin PC, Shah BR, Wu J, Gill
SS and Booth GL: Risk of dementia in seniors with newly diagnosed
diabetes: A population-based study. Diabetes Care. 38:1868–1875.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ruegsegger GN, Vanderboom PM, Dasari S,
Klaus KA, Kabiraj P, McCarthy CB, Lucchinetti CF and Nair KS:
Exercise and metformin counteract altered mitochondrial function in
the insulin-resistant brain. JCI Insight. 4:e1306812019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kullmann S, Goj T, Veit R, Fritsche L,
Wagner L, Schneeweiss P, Hoene M, Hoffmann C, Machann J, Niess A,
et al: Exercise restores brain insulin sensitivity in sedentary
adults who are overweight and obese. JCI Insight. 7:e1614982022.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim B and Feldman EL: Insulin resistance
in the nervous system. Trends Endocrinol Metab. 23:133–141. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Delgado-Peraza F, Nogueras-Ortiz C,
Simonsen AH, Knight DD, Yao PJ, Goetzl EJ, Jensen CS, Høgh P,
Gottrup H, Vestergaard K, et al: Neuron-derived extracellular
vesicles in blood reveal effects of exercise in Alzheimer's
disease. Alzheimers Res Ther. 15:1562023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dahiya M, Yadav M, Goyal C and Kumar A:
Insulin resistance in Alzheimer's disease: Signalling mechanisms
and therapeutics strategies. Inflammopharmacology. 33:1817–1831.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Malin SK, Battillo DJ, Beeri MS, Mustapic
M, Delgado-Peraza F and Kapogiannis D: Two weeks of exercise alters
neuronal extracellular vesicle insulin signaling proteins and
pro-BDNF in older adults with prediabetes. Aging Cell.
24:e143692025. View Article : Google Scholar
|
|
28
|
Da Mesquita S, Papadopoulos Z, Dykstra T,
Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J,
et al: Meningeal lymphatics affect microglia responses and anti-Aβ
immunotherapy. Nature. 593:255–260. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li P, Chen J, Wang X, Su Z, Gao M and
Huang Y: Liquid-liquid phase separation of tau: Driving forces,
regulation, and biological implications. Neurobiol Dis.
183:1061672023. View Article : Google Scholar
|
|
30
|
Wang Y, Cella M, Mallinson K, Ulrich JD,
Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S,
Zinselmeyer BH, et al: TREM2 lipid sensing sustains the microglial
response in an Alzheimer's disease model. Cell. 160:1061–1071.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kellar D and Craft S: Brain insulin
resistance in Alzheimer's disease and related disorders: mechanisms
and therapeutic approaches. Lancet Neurol. 19:758–766. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chandra S, Sisodia SS and Vassar RJ: The
gut microbiome in Alzheimer's disease: What we know and what
remains to be explored. Mol Neurodegener. 18:92023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sienski G, Narayan P, Bonner JM, Kory N,
Boland S, Arczewska AA, Ralvenius WT, Akay L, Lockshin E, He L, et
al: APOE4 disrupts intracellular lipid homeostasis in human
iPSC-derived glia. Sci Transl Med. 13:eaaz45642021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bellenguez C, Küçükali F, Jansen IE,
Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R,
Grenier-Boley B, Andrade V, et al: New insights into the genetic
etiology of Alzheimer's disease and related dementias. Nat Genet.
54:412–436. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu H, Dunnett S, Ho YS and Chang RCC: The
role of sleep deprivation and circadian rhythm disruption as risk
factors of Alzheimer's disease. Front Neuroendocrinol.
54:1007642019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hussain R, Graham U, Elder A and
Nedergaard M: Air pollution, glymphatic impairment, and Alzheimer's
disease. Trends Neurosci. 46:901–911. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Myhre O, Utkilen H, Duale N, Brunborg G
and Hofer T: Metal dyshomeostasis and inflammation in Alzheimer's
and Parkinson's diseases: Possible impact of environmental
exposures. Oxid Med Cell Longev. 2013:7269542013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Chen Y, Zhang C, Xiang Z, Ding J
and Han X: Learning and memory deficits and alzheimer's
disease-like changes in mice after chronic exposure to
microcystin-LR. J Hazard Mater. 373:504–518. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Goldman SM: Environmental toxins and
Parkinson's disease. Annu Rev Pharmacol Toxicol. 54:141–164. 2014.
View Article : Google Scholar
|
|
40
|
Vasefi M, Ghaboolian-Zare E, Abedelwahab H
and Osu A: Environmental toxins and Alzheimer's disease
progression. Neurochem Int. 141:1048522020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bovis K, Davies-Branch M and Day PJR:
Dysregulated neurotransmission and the role of viruses in
Alzheimer's disease. ACS Chem Neurosci. 16:982–987. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dai L, Zou L, Meng L, Qiang G, Yan M and
Zhang Z: Cholesterol metabolism in neurodegenerative diseases:
Molecular mechanisms and therapeutic targets. Mol Neurobiol.
58:2183–2201. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Y, Zhang J, Wan J, Liu A and Sun J:
Melatonin regulates Aβ production/clearance balance and Aβ
neurotoxicity: A potential therapeutic molecule for Alzheimer's
disease. Biomed Pharmacother. 132:1108872020. View Article : Google Scholar
|
|
44
|
Manucat-Tan NB, Shen LL, Bobrovskaya L,
Al-Hawwas M, Zhou FH, Wang YJ and Zhou XF: Knockout of p75
neurotrophin receptor attenuates the hyperphosphorylation of Tau in
pR5 mouse model. Aging (Albany NY). 11:6762–6791. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bie B, Wu J, Lin F, Naguib M and Xu J:
Suppression of hippocampal GABAergic transmission impairs memory in
rodent models of Alzheimer's disease. Eur J Pharmacol.
917:1747712022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aarsland D, Batzu L, Halliday GM, Geurtsen
GJ, Ballard C, Ray Chaudhuri K and Weintraub D: Parkinson
disease-associated cognitive impairment. Nat Rev Dis Primers.
7:472021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jellinger KA: Morphological basis of
Parkinson disease-associated cognitive impairment: An update. J
Neural Transm (Vienna). 129:977–999. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Goldman JG and Sieg E: Cognitive
impairment and dementia in Parkinson disease. Clin Geriatr Med.
36:365–377. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Baiano C, Barone P, Trojano L and
Santangelo G: Prevalence and clinical aspects of mild cognitive
impairment in Parkinson's disease: A meta-analysis. Mov Disord.
35:45–54. 2020. View Article : Google Scholar
|
|
50
|
Ali NH, Al-Kuraishy HM, Al-Gareeb AI,
Alnaaim SA, Saad HM and Batiha GES: The molecular pathway of p75
neurotrophin receptor (p75NTR) in Parkinson's disease: The way of
new inroads. Mol Neurobiol. 61:2469–2480. 2024. View Article : Google Scholar
|
|
51
|
Kazzi C, Alpitsis R, O'Brien TJ, Malpas CB
and Monif M: Cognitive and psychopathological features of
neuromyelitis optica spectrum disorder and myelin oligodendrocyte
glycoprotein antibody-associated disease: A narrative review. Mult
Scler Relat Disord. 85:1055962024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jellinger KA: Cognitive impairment in
multiple sclerosis: From phenomenology to neurobiological
mechanisms. J Neural Transm (Vienna). 131:871–899. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hu ZL, Luo C, Hurtado PR, Li H, Wang S, Hu
B, Xu JM, Liu Y, Feng SQ, Hurtado-Perez E, et al: Brain-derived
neurotrophic factor precursor in the immune system is a novel
target for treating multiple sclerosis. Theranostics. 11:715–730.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Al-Yozbaki M, Acha-Sagredo A, George A,
Liloglou T and Wilson CM: Balancing neurotrophin pathway and
sortilin function: Its role in human disease. Biochim Biophys Acta
Rev Cancer. 1874:1884292020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vilar M: Structural characterization of
the p75 neurotrophin receptor: A stranger in the TNFR superfamily.
Vitam Horm. 104:57–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen C, Li J, Matye DJ, Wang Y and Li T:
Hepatocyte sortilin 1 knockout and treatment with a sortilin 1
inhibitor reduced plasma cholesterol in Western diet-fed mice. J
Lipid Res. 60:539–549. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li Q, Hu YZ, Gao S, Wang PF, Hu ZL and Dai
RP: ProBDNF and its receptors in immune-mediated inflammatory
diseases: Novel insights into the regulation of metabolism and
mitochondria. Front Immunol. 14:11553332023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Al-Kuraishy HM, Sulaiman GM, Mohammed HA,
Albukhaty S, Albuhadily AK, Al-Gareeb AI, Klionsky DJ and
Abomughaid MM: The compelling role of brain-derived neurotrophic
factor signaling in multiple sclerosis: Role of BDNF activators.
CNS Neurosci Ther. 30:e701672024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Reuter E, Weber J, Paterka M, Ploen R,
Breiderhoff T, van Horssen J, Willnow TE, Siffrin V and Zipp F:
Role of sortilin in models of autoimmune neuroinflammation. J
Immunol. 195:5762–5769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Sarno E, Moeser AJ and Robison AJ:
Neuroimmunology of depression. Adv Pharmacol. 91:259–292. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Price RB and Duman R: Neuroplasticity in
cognitive and psychological mechanisms of depression: An
integrative model. Mol Psychiatry. 25:530–543. 2020. View Article : Google Scholar :
|
|
62
|
Pan Z, Park C, Brietzke E, Zuckerman H,
Rong C, Mansur RB, Fus D, Subramaniapillai M, Lee Y and Mcintyre
RS: Cognitive impairment in major depressive disorder. CNS Spectr.
24:22–29. 2019. View Article : Google Scholar
|
|
63
|
Zhao XP, Li H and Dai RP: Neuroimmune
crosstalk through brain-derived neurotrophic factor and its
precursor pro-BDNF: New insights into mood disorders. World J
Psychiatry. 12:379–392. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lin LY, Kelliny S, Liu LC, Al-Hawwas M,
Zhou XF and Bobrovskaya L: Peripheral ProBDNF delivered by an AAV
vector to the muscle triggers depression-like behaviours in mice.
Neurotox Res. 38:626–639. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang CR, Liang R, Liu Y, Meng FJ, Zhou F,
Zhang XY, Ning L, Wang ZQ, Liu S and Zhou XF: Upregulation of
proBDNF/p75NTR signaling in immune cells and its correlation with
inflammatory markers in patients with major depression. FASEB J.
38:e233122024. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li Y, Guan X, He Y, Jia X, Pan L, Wang Y,
Han Y, Zhao R, Yang J and Hou T: ProBDNF signaling is involved in
periodontitis-induced depression-like behavior in mouse
hippocampus. Int Immunopharmacol. 116:1097672023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Li Y, Yang Y, Guan X, Liu Z, Pan L, Wang
Y, Jia X, Yang J and Hou T: SorCS2 is involved in promoting
periodontitis-induced depression-like behaviour in mice. Oral Dis.
30:5408–5420. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jin HJ, Pei L, Li YN, Zheng H, Yang S, Wan
Y, Mao L, Xia YP, He QW, Li M, et al: Alleviative effects of
fluoxetine on depressive-like behaviors by epigenetic regulation of
BDNF gene transcription in mouse model of post-stroke depression.
Sci Rep. 7:149262017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Yang B, Wang L, Nie Y, Wei W and Xiong W:
proBDNF expression induces apoptosis and inhibits synaptic
regeneration by regulating the RhoA-JNK pathway in an in vitro
post-stroke depression model. Transl Psychiatry. 11:5782021.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Huang S, Nie Y, Qin J, Wen M, Wang Q, Xie
F, Song F and Yang B: Hippocampal exosomes from stroke aggravate
post-stroke depression by regulating the expression of proBDNF and
p75NTR and altering spine density. Sci Rep. 14:282232024.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sanmarti M, Ibáñez L, Huertas S, Badenes
D, Dalmau D, Slevin M, Krupinski J, Popa-Wagner A and Jaen A:
Hiv-associated neurocognitive disorders. J Mol Psychiatry. 2:22014.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Saylor D, Dickens AM, Sacktor N, Haughey
N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ and
Mcarthur JC: Hiv-associated neurocognitive disorder-pathogenesis
and prospects for treatment. Nat Rev Neurol. 12:234–248. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Antinori A, Arendt G, Becker JT, Brew BJ,
Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K,
et al: Updated research nosology for HIV-associated neurocognitive
disorders. Neurology. 69:1789–1799. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kaul M, Zheng J, Okamoto S, Gendelman HE
and Lipton SA: HIV-1 infection and AIDS: Consequences for the
central nervous system. Cell Death Differ. 12(Suppl 1): S878–S892.
2005. View Article : Google Scholar
|
|
75
|
Eggers C, Arendt G, Hahn K, Husstedt IW,
Maschke M, Neuen-Jacob E, Obermann M, Rosenkranz T, Schielke E and
Straube E; German Association of Neuro-AIDS und Neuro-Infectiology
(DGNANI): HIV-1-associated neurocognitive disorder: Epidemiology,
pathogenesis, diagnosis, and treatment. J Neurol. 264:1715–1727.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Avedissian SN, Dyavar SR, Fox HS and
Fletcher CV: Pharmacologic approaches to HIV-associated
neurocognitive disorders. Curr Opin Pharmacol. 54:102–108. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Erdos T, Masuda M and Venketaraman V:
Glutathione in HIV-associated neurocognitive disorders. Curr Issues
Mol Biol. 46:5530–5549. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Riviere-Cazaux C, Cornell J, Shen Y and
Zhou M: The role of CCR5 in HIV-associated neurocognitive
disorders. Heliyon. 8:e99502022. View Article : Google Scholar
|
|
79
|
Hou C, Wei J, Zhang H and Li H: Evolving
strategies in the diagnosis and treatment of HIV-associated
neurocognitive disorders. Rev Neurosci. Mar 6–2025.Epub ahead of
print. View Article : Google Scholar
|
|
80
|
Johnson TP and Nath A: Biotypes of
HIV-associated neurocognitive disorders based on viral and immune
pathogenesis. Curr Opin Infect Dis. 35:223–230. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Speidell A, Asuni GP, Wakulski R and
Mocchetti I: Up-regulation of the p75 neurotrophin receptor is an
essential mechanism for HIV-gp120 mediated synaptic loss in the
striatum. Brain Behav Immun. 89:371–379. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Allen CNS, Arjona SP, Santerre M, De Lucia
C, Koch WJ and Sawaya BE: Metabolic reprogramming in HIV-associated
neurocognitive disorders. Front Cell Neurosci. 16:8128872022.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Michael HU, Rapulana AM, Smit T, Xulu N,
Danaviah S, Ramlall S and Oosthuizen F: Serum mature and precursor
brain-derived neurotrophic factors and their association with
neurocognitive function in ART-Naïve adults living with HIV in
Sub-Saharan Africa. Mol Neurobiol. 62:5442–5451. 2025. View Article : Google Scholar
|
|
84
|
Mizoguchi Y, Ohgidani M, Haraguchi Y,
Murakawa-Hirachi T, Kato TA and Monji A: ProBDNF induces sustained
elevation of intracellular Ca2+ possibly mediated by
TRPM7 channels in rodent microglial cells. Glia. 69:1694–1708.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sonneville R, de Montmollin E, Poujade J,
Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L,
Barbier F, Goldgran-Toledano D, et al: Potentially modifiable
factors contributing to sepsis-associated encephalopathy. Intensive
Care Med. 43:1075–1084. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Long LH, Cao WY, Xu Y and Xiang YY:
Research progress on the role of microglia in sepsis-associated
encephalopathy. Sheng Li Xue Bao. 76:289–300. 2024.In Chinese.
PubMed/NCBI
|
|
87
|
Luo RY, Luo C, Zhong F, Shen WY, Li H, Hu
ZL and Dai RP: ProBDNF promotes sepsis-associated encephalopathy in
mice by dampening the immune activity of meningeal CD4+
T cells. J Neuroinflammation. 17:1692020. View Article : Google Scholar
|
|
88
|
Huang J, Chen L, Yao ZM, Sun XR, Tong XH
and Dong SY: The role of mitochondrial dynamics in cerebral
ischemia-reperfusion injury. Biomed Pharmacother. 162:1146712023.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wu M, Gu X and Ma Z: Mitochondrial quality
control in cerebral ischemia-reperfusion injury. Mol Neurobiol.
58:5253–5271. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kumar SS and Singh D: Mitochondrial
mechanisms in cerebral ischemia-reperfusion injury: Unravelling the
intricacies. Mitochondrion. 77:1018832024. View Article : Google Scholar
|
|
91
|
Fiskum G, Murphy AN and Beal MF:
Mitochondria in neurodegeneration: Acute ischemia and chronic
neurodegenerative diseases. J Cereb Blood Flow Metab. 19:351–369.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Jurcau A and Simion A: Neuroinflammation
in cerebral ischemia and ischemia/reperfusion injuries: From
pathophysiology to therapeutic strategies. Int J Mol Sci.
23:142021. View Article : Google Scholar
|
|
93
|
Yang K, Zeng L, Ge A, Wang S, Zeng J, Yuan
X, Mei Z, Wang G and Ge J: A systematic review of the research
progress of non-coding RNA in neuroinflammation and immune
regulation in cerebral infarction/ischemia-reperfusion injury.
Front Immunol. 13:9301712022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhang Q, Jia M, Wang Y, Wang Q and Wu J:
Cell death mechanisms in cerebral ischemia-reperfusion injury.
Neurochem Res. 47:3525–3542. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Liu X, Xie C, Wang Y, Xiang J, Chen L,
Yuan J, Chen C and Tian H: Ferritinophagy and ferroptosis in
cerebral ischemia reperfusion injury. Neurochem Res. 49:1965–1979.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Li M, Tang H, Li Z and Tang W: Emerging
treatment strategies for cerebral ischemia-reperfusion injury.
Neuroscience. 507:112–124. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ginsberg MD: Neuroprotection for ischemic
stroke: Past, present and future. Neuropharmacology. 55:363–389.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chamorro A, Dirnagl U, Urra X and Planas
AM: Neuroprotection in acute stroke: Targeting excitotoxicity,
oxidative and nitrosative stress, and inflammation. Lancet Neurol.
15:869–881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Xiong XY, Liu L and Yang QW: Functions and
mechanisms of microglia/macrophages in neuroinflammation and
neurogenesis after stroke. Prog Neurobiol. 142:23–44. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu
J, Gao F, Wang S, Tan R and Yuan J: Ischemia-reperfusion injury:
Molecular mechanisms and therapeutic targets. Signal Transduct
Target Ther. 9:122024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Liu DQ, Mei W, Zhou YQ and Xi H: Targeting
TRPM channels for cerebral ischemia-reperfusion injury. Trends
Pharmacol Sci. 45:862–867. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Candelario-Jalil E, Dijkhuizen RM and
Magnus T: Neuroinflammation, stroke, blood-brain barrier
dysfunction, and imaging modalities. Stroke. 53:1473–1486. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yang C, Hawkins KE, Doré S and
Candelario-Jalil E: Neuroinflammatory mechanisms of blood-brain
barrier damage in ischemic stroke. Am J Physiol Cell Physiol.
316:C135–C153. 2019. View Article : Google Scholar :
|
|
104
|
Li S, Dou B, Shu S, Wei L, Zhu S, Ke Z and
Wang Z: Suppressing NK Cells by astragaloside IV protects against
acute ischemic stroke in mice via inhibiting STAT3. Front
Pharmacol. 12:8020472022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Cramer T, Gill R, Thirouin ZS, Vaas M,
Sampath S, Martineau F, Noya SB, Panzanelli P, Sudharshan TJJ,
Colameo D, et al: Cross-talk between GABAergic postsynapse and
microglia regulate synapse loss after brain ischemia. Sci Adv.
8:eabj1122022. View Article : Google Scholar
|
|
106
|
Rahman M, Luo H, Bobrovskaya L and Zhou
XF: Neuroprotective effects of anti-probdnf in a RAT
photothrombotic ischemic model. Neuroscience. 446:261–270. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kotekar N, Shenkar A and Nagaraj R:
Postoperative cognitive dysfunction-current preventive strategies.
Clin Interv Aging. 13:2267–2273. 2018. View Article : Google Scholar :
|
|
108
|
Yang X, Huang X, Li M, Jiang Y and Zhang
H: Identification of individuals at risk for postoperative
cognitive dysfunction (POCD). Ther Adv Neurol Disord.
15:175628642211143562022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhong Y, Zhang Y and Zhu Z: Research
progress on the association between MicroRNA and postoperative
cognitive dysfunction. Minerva Anestesiol. 90:191–199. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Luo A, Yan J, Tang X, Zhao Y, Zhou B and
Li S: Postoperative cognitive dysfunction in the aged: The
collision of neuroinflammaging with perioperative
neuroinflammation. Inflammopharmacology. 27:27–37. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Xue Z, Shui M, Lin X, Sun Y, Liu J, Wei C,
Wu A and Li T: Role of BDNF/ProBDNF imbalance in postoperative
cognitive dysfunction by modulating synaptic plasticity in aged
mice. Front Aging Neurosci. 14:7809722022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Jiang L, Dong R, Xu M, Liu Y, Xu J, Ma Z,
Xia T and Gu X: Inhibition of the integrated stress response
reverses oxidative stress damage-induced postoperative cognitive
dysfunction. Front Cell Neurosci. 16:9928692022. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (Sepsis-3). JAMA.
315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Hotchkiss RS, Moldawer LL, Opal SM,
Reinhart K, Turnbull IR and Vincent JL: Sepsis and septic shock.
Nat Rev Dis Primers. 2:160452016. View Article : Google Scholar
|
|
115
|
Fleischmann C, Scherag A, Adhikari NKJ,
Hartog CS, Tsaganos T, Schlattmann P, Angus DC and Reinhart K;
International Forum of Acute Care Trialists: Assessment of global
incidence and mortality of hospital-treated sepsis. Current
estimates and limitations. Am J Respir Crit Care Med. 193:259–272.
2016. View Article : Google Scholar
|
|
116
|
Wang Z, Wu JL, Zhong F, Liu Y, Yu YQ, Sun
JJ, Wang S, Li H, Zhou XF, Hu ZL and Dai RP: Upregulation of
proBDNF in the mesenteric lymph nodes in septic mice. Neurotox Res.
36:540–550. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Wang S, Zeng Q, Gao H, Gao S, Dai R and Hu
Z: Expression of proBDNF/p75NTR in peripheral blood
lymphocytes of patients with sepsis and its impact on lymphocyte
differentiation. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 48:1629–1638.
2023.In English, Chinese.
|
|
118
|
Bezzio C, Della CC, Vernero M, Di Luna I,
Manes G and Saibeni S: Inflammatory bowel disease and
immune-mediated inflammatory diseases: Looking at the less frequent
associations. Therap Adv Gastroenterol. 15:175628482211153122022.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Yang CR, Ding HJ, Yu M, Zhou FH, Han CY,
Liang R, Zhang XY, Zhang XL, Meng FJ, Wang S, et al: proBDNF/p75NTR
promotes rheumatoid arthritis and inflammatory response by
activating proinflammatory cytokines. FASEB J.
36:e221802022.PubMed/NCBI
|
|
120
|
Farina L, Minnone G, Alivernini S, Caiello
I, MacDonald L, Soligo M, Manni L, Tolusso B, Coppola S, Zara E, et
al: Pro nerve growth factor and its receptor p75NTR activate
inflammatory responses in synovial fibroblasts: A novel targetable
mechanism in arthritis. Front Immunol. 13:8186302022. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Ameer MA, Chaudhry H, Mushtaq J, Khan OS,
Babar M, Hashim T, Zeb S, Tariq MA, Patlolla SR, Ali J, et al: An
overview of systemic lupus erythematosus (SLE) pathogenesis,
classification, and management. Cureus. 14:e303302022.PubMed/NCBI
|
|
122
|
Shen WY, Luo C, Hurtado PR, Liu XJ, Luo
RY, Li H, Hu ZL, Xu JM, Coulson EJ, Zhao M, et al: Up-regulation of
proBDNF/p75NTR signaling in antibody-secreting cells
drives systemic lupus erythematosus. Sci Adv. 8:eabj27972022.
View Article : Google Scholar
|
|
123
|
Putcha GV, Moulder KL, Golden JP, Bouillet
P, Adams JA, Strasser A and Johnson EM: Induction of BIM, a
proapoptotic BH3-only BCL-2 family member, is critical for neuronal
apoptosis. Neuron. 29:615–628. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Sankorrakul K, Qian L, Thangnipon W and
Coulson EJ: Is there a role for the p75 neurotrophin receptor in
mediating degeneration during oxidative stress and after hypoxia? J
Neurochem. 158:1292–1306. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Taylor KR, Barron T, Hui A, Spitzer A,
Yalçin B, Ivec AE, Geraghty AC, Hartmann GG, Arzt M, Gillespie SM,
et al: Glioma synapses recruit mechanisms of adaptive plasticity.
Nature. 623:366–374. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Jiang CC, Marsland M, Wang Y, Dowdell A,
Eden E, Gao F, Faulkner S, Jobling P, Li X, Liu L, et al: Tumor
innervation is triggered by endoplasmic reticulum stress. Oncogene.
41:586–599. 2022. View Article : Google Scholar
|
|
127
|
Xiong J, Zhou L, Yang M, Lim Y, Zhu YH, Fu
DL, Li ZW, Zhong JH, Xiao ZC and Zhou XF: ProBDNF and its receptors
are upregulated in glioma and inhibit the growth of glioma cells in
vitro. Neuro Oncol. 15:990–1007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Fan YJ, Wu LLY, Li HY, Wang YJ and Zhou
XF: Differential effects of pro-BDNF on sensory neurons after
sciatic nerve transection in neonatal rats. Eur J Neurosci.
27:2380–2390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Koshimizu H, Hazama S, Hara T, Ogura A and
Kojima M: Distinct signaling pathways of precursor BDNF and mature
BDNF in cultured cerebellar granule neurons. Neurosci Lett.
473:229–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Salmaggi A, Croci D, Prina P, Cajola L,
Pollo B, Marras CE, Ciusani E, Silvani A, Boiardi A and Sciacca FL:
Production and post-surgical modification of VEGF, tPA and PAI-1 in
patients with glioma. Cancer Biol Ther. 5:204–209. 2006. View Article : Google Scholar
|
|
131
|
Nakabayashi H, Yawata T and Shimizu K:
Anti-invasive and antiangiogenic effects of MMI-166 on malignant
glioma cells. BMC Cancer. 10:3392010. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Levicar N, Nuttall RK and Lah TT:
Proteases in brain tumour progression. Acta Neurochir (Wien).
145:825–838. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
De la Cruz-Morcillo MA, Berger J,
Sánchez-Prieto R, Saada S, Naves T, Guillaudeau A, Perraud A,
Sindou P, Lacroix A, Descazeaud A, et al: p75 neurotrophin receptor
and pro-BDNF promote cell survival and migration in clear cell
renal cell carcinoma. Oncotarget. 7:34480–34497. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Corti C, Antonarelli G, Criscitiello C,
Lin NU, Carey LA, Cortés J, Poortmans P and Curigliano G: Targeting
brain metastases in breast cancer. Cancer Treat Rev.
103:1023242022. View Article : Google Scholar
|
|
135
|
Fidler IJ: The biology of brain
metastasis: Challenges for therapy. Cancer J. 21:284–293. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Alhusban L, Ayoub NM and Alhusban A:
ProBDNF is a novel mediator of the interaction between MDA-MB-231
breast cancer cells and brain microvascular endothelial cells. Curr
Mol Med. 21:914–921. 2021. View Article : Google Scholar
|
|
137
|
Klann IP, Fulco BCW and Nogueira CW:
Subchronic exposure to Tamoxifen modulates the hippocampal
BDNF/ERK/Akt/CREB pathway and impairs memory in intact female rats.
Chem Biol Interact. 382:1106152023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Tajbakhsh A, Mokhtari-Zaer A, Rezaee M,
Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A and Avan
A: Therapeutic potentials of BDNF/TrkB in breast cancer; current
status and perspectives. J Cell Biochem. 118:2502–2515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Lu Q, Qu Y, Ding Y and Kang X:
p75NTR/proBDNF modulates basal cell carcinoma (BCC) immune
microenvironment via necroptosis signaling pathway. J Immunol Res.
2021:66528462021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Culig L, Chu X and Bohr VA: Neurogenesis
in aging and age-related neurodegenerative diseases. Ageing Res
Rev. 78:1016362022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Bhalla M and Lee CJ: Long-term inhibition
of ODC1 in APP/PS1 mice rescues amyloid pathology and switches
astrocytes from a reactive to active state. Mol Brain. 17:32024.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Sunderland S: A classification of
peripheral nerve injuries producing loss of function. Brain.
74:491–516. 1951. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Kamble N, Shukla D and Bhat D: Peripheral
nerve injuries: Electrophysiology for the neurosurgeon. Neurol
India. 67:1419–1422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Gordon T: Peripheral nerve regeneration
and muscle reinnervation. Int J Mol Sci. 21:86522020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Rotshenker S: Wallerian degeneration: The
innate-immune response to traumatic nerve injury. J
Neuroinflammation. 8:1092011. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Defrancesco-Lisowitz A, Lindborg JA, Niemi
JP and Zigmond RE: The neuroimmunology of degeneration and
regeneration in the peripheral nervous system. Neuroscience.
302:174–203. 2015. View Article : Google Scholar
|
|
147
|
Cámara-Lemarroy CR, Guzmán-de la Garza FJ
and Fernández-Garza NE: Molecular inflammatory mediators in
peripheral nerve degeneration and regeneration.
Neuroimmunomodulation. 17:314–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Huang EJ and Reichardt LF: Neurotrophins:
Roles in neuronal development and function. Annu Rev Neurosci.
24:677–736. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Jessen KR and Mirsky R: The repair schwann
cell and its function in regenerating nerves. J Physiol.
594:3521–3531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wang X, Ma W, Wang T, Yang J, Wu Z, Liu K,
Dai Y, Zang C, Liu W, Liu J, et al: BDNF-TrkB and
proBDNF-p75NTR/Sortilin signaling pathways are involved in
mitochondria-mediated neuronal apoptosis in dorsal root ganglia
after sciatic nerve transection. CNS Neurol Disord Drug Targets.
19:66–82. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Ma W, Yang JW, Wang XB, Luo T, Zhou L,
Lagares A, Li H, Liang Z, Liu KP, Zang CH, et al: Negative
regulation by proBDNF signaling of peripheral neurogenesis in the
sensory ganglia of adult rats. Biomed Pharmacother. 144:1122732021.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Fronza MG, Ferreira BF, Pavan-Silva I,
Guimarães FS and Lisboa SF: 'NO' time in fear response: Possible
implication of nitric-oxide-related mechanisms in PTSD. Molecules.
29:892023. View Article : Google Scholar
|
|
153
|
He M, Wei JX, Mao M, Zhao GY, Tang JJ,
Feng S, Lu XM and Wang YT: Synaptic plasticity in PTSD and
associated comorbidities: The function and mechanism for
diagnostics and therapy. Curr Pharm Des. 24:4051–4059. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Andero R and Ressler KJ: Fear extinction
and BDNF: Translating animal models of PTSD to the clinic. Genes
Brain Behav. 11:503–512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Bennett MR, Hatton SN and Lagopoulos J:
Stress, trauma and PTSD: Translational insights into the core
synaptic circuitry and its modulation. Brain Struct Funct.
221:2401–2426. 2016. View Article : Google Scholar
|
|
156
|
Sagarwala R and Nasrallah HA: Changes in
inflammatory biomarkers before and after SSRI therapy in PTSD: A
review. Ann Clin Psychiatry. 31:292–297. 2019.PubMed/NCBI
|
|
157
|
Meis S, Endres T and Lessmann V:
Neurotrophin signalling in amygdala-dependent cued fear learning.
Cell Tissue Res. 382:161–172. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Beckers T and Kindt M: Memory
reconsolidation interference as an emerging treatment for emotional
disorders: Strengths, limitations, challenges, and opportunities.
Annu Rev Clin Psychol. 13:99–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Sun W, Chen X, Mei Y, Yang Y, Li X and An
L: Prelimbic proBDNF facilitates retrieval-dependent fear memory
destabilization by regulation of synaptic and neural functions in
juvenile rats. Mol Neurobiol. 59:4179–4196. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Ma X, Vuyyuru H, Munsch T, Endres T,
Lessmann V and Meis S: ProBDNF dependence of LTD and fear
extinction learning in the amygdala of adult mice. Cereb Cortex.
32:1350–1364. 2022. View Article : Google Scholar
|
|
161
|
Machado BSJ, Cardoso NC, Raymundi AM,
Prickaerts J and Stern CAJ: Phosphodiesterase 4 inhibition after
retrieval switches the memory fate favoring extinction instead of
reconsolidation. Sci Rep. 13:203842023. View Article : Google Scholar
|
|
162
|
van der Merwe RK, Nadel JA, Copes-Finke D,
Pawelko S, Scott JS, Ghanem M, Fox M, Morehouse C, Mclaughlin R,
Maddox C, et al: Characterization of striatal dopamine projections
across striatal subregions in behavioral flexibility. Eur J
Neurosci. 58:4466–4486. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Sun W, Che H, Li J, Tang D, Liu X, Liu W
and An L: Dorsolateral striatal proBDNF improves reversal learning
by enhancing coordination of neural activity in rats. Mol
Neurobiol. 57:4642–4656. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Zheng W: Implicit motor learning in
children with autism spectrum disorder: Current approaches and
future directions. Front Psychiatry. 15:12531992024. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Hughes HK, Moreno RJ and Ashwood P: Innate
immune dysfunction and neuroinflammation in autism spectrum
disorder (ASD). Brain Behav Immun. 108:245–254. 2023. View Article : Google Scholar
|
|
166
|
Robinson-Agramonte MDLA, Michalski B,
Vidal-Martinez B, Hernández LR, Santiesteban MW and Fahnestock M:
BDNF, proBDNF and IGF-1 serum levels in naïve and medicated
subjects with autism. Sci Rep. 12:137682022. View Article : Google Scholar
|
|
167
|
Armstrong MJ and Okun MS: Diagnosis and
treatment of parkinson disease: A review. JAMA. 323:548–560. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yi X, Yang Y, Zhao Z, Xu M, Zhang Y, Sheng
Y, Tian J and Xu Z: Serum mBDNF and ProBDNF expression levels as
diagnosis clue for early stage Parkinson's disease. Front Neurol.
12:6807652021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Li Y, Chen J, Yu H, Ye J, Wang C and Kong
L: Serum brain-derived neurotrophic factor as diagnosis clue for
Alzheimer's disease: A cross-sectional observational study in the
elderly. Front Psychiatry. 14:11276582023. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Campisi J, Kapahi P, Lithgow GJ, Melov S,
Newman JC and Verdin E: From discoveries in ageing research to
therapeutics for healthy ageing. Nature. 571:183–192. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Norgren J, Daniilidou M, Kåreholt I, Sindi
S, Akenine U, Nordin K, Rosenborg S, Ngandu T, Kivipelto M and
Sandebring-Matton A: Serum proBDNF is associated with changes in
the ketone body β-hydroxybutyrate and shows superior repeatability
over mature BDNF: Secondary outcomes from a cross-over trial in
healthy older adults. Front Aging Neurosci. 13:7165942021.
View Article : Google Scholar
|
|
172
|
Yu WR, Jiang YH, Jhang JF and Kuo HC:
Urine biomarker could be a useful tool for differential diagnosis
of a lower urinary tract dysfunction. Tzu Chi Med J. 36:110–119.
2023.
|
|
173
|
Nitti VW, Patel A and Karram M: Diagnosis
and management of overactive bladder: A review. J Obstet Gynaecol
Res. 47:1654–1665. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Malde S, Kelly S, Saad S and Sahai A:
Case-finding tools for the diagnosis of OAB in women: A narrative
review. Neurourol Urodyn. 39:13–24. 2020. View Article : Google Scholar
|
|
175
|
Covarrubias C, Cammisotto PG, Shamout S
and Campeau L: Decrease in the ratio proBDNF/BDNF in the urine of
aging female patients with OAB. Metabolites. 13:7232023. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Gelle T, Sa mey R A, Pla nsont B, Besset
te B, Jauberteau-Marchan MO, Lalloué F and Girard M: BDNF and
pro-BDNF in serum and exosomes in major depression: Evolution after
antidepressant treatment. Prog Neuropsychopharmacol Biol
Psychiatry. 109:1102292021. View Article : Google Scholar
|
|
177
|
Yang Z, Gao C, Li Z, Jiang T, Liang Y,
Jiang T, Yu C, Yan S, Li P and Zhou L: The changes of tPA/PAI-1
system are associated with the ratio of BDNF/proBDNF in major
depressive disorder and SSRIs antidepressant treatment.
Neuroscience. 559:220–228. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Lin L, Fu XY, Zhou XF, Liu D, Bobrovskaya
L and Zhou L: Analysis of blood mature BDNF and proBDNF in mood
disorders with specific ELISA assays. J Psychiatr Res. 133:166–173.
2021. View Article : Google Scholar
|
|
179
|
Zwolińska W, Skibinska M, Słopień A and
Dmitrzak-Weglarz M: ProBDNF as an indicator of improvement among
women with depressive episodes. Metabolites. 12:3582022. View Article : Google Scholar
|
|
180
|
Shen WY, Luo C, Reinaldo HP, Hurtado-Perez
E, Luo RY, Hu ZL, Li H, Xu JM, Zhou XF and Dai RP: The regulatory
role of ProBDNF in monocyte function: Implications in Stanford
type-A aortic dissection disease. FASEB J. 34:2541–2553. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Luo C, Zhong XL, Zhou FH, Li JY, Zhou P,
Xu JM, Song B, Li CQ, Zhou XF and Dai RP: Peripheral brain derived
neurotrophic factor precursor regulates pain as an inflammatory
mediator. Sci Rep. 6:271712016. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Li H, Liu T, Sun J, Zhao S, Wang X, Luo W,
Luo R, Shen W, Luo C and Fu D: Up-regulation of
ProBDNF/p75NTR signaling in spinal cord drives
inflammatory pain in male rats. J Inflamm Res. 16:95–107. 2023.
View Article : Google Scholar :
|
|
183
|
Zha AH, Luo C, Shen WY, Fu D and Dai RP:
Systemic blockade of proBDNF inhibited the expansion and altered
the transcriptomic expression in CD3+B220+
cells in MRL/lpr lupus mice. Lupus Sci Med. 9:e0008362022.
View Article : Google Scholar
|
|
184
|
Li JN, Luo RY, Luo C, Hu ZL, Zha AH, Shen
WY, Li Q, Li H, Fu D and Dai RP: Brain-derived neurotrophic factor
precursor contributes to a proinflammatory program in
monocytes/macrophages after acute myocardial infarction. J Am Heart
Assoc. 12:e281982023. View Article : Google Scholar
|
|
185
|
Cui YH, Zhou SF, Liu Y, Wang S, Li F, Dai
RP, Hu ZL and Li CQ: Injection of anti-proBDNF attenuates
hippocampal-dependent learning and memory dysfunction in mice with
sepsis-associated encephalopathy. Front Neurosci. 15:6657572021.
View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lim Y, Zhong JH and Zhou XF: Development
of mature BDNF-specific sandwich ELISA. J Neurochem. 134:75–85.
2015. View Article : Google Scholar : PubMed/NCBI
|
